Search Results

There are 8766 results for: content related to: Muscle biopsy substantiates long-term MRI alterations one year after a single dose of botulinum toxin injected into the lateral gastrocnemius muscle of healthy volunteers

  1. Basic immunological aspects of botulinum toxin therapy

    Movement Disorders

    Volume 19, Issue S8, March 2004, Pages: S68–S84, M. Zouhair Atassi

    Article first published online : 9 MAR 2004, DOI: 10.1002/mds.20020

  2. Is the light chain subcellular localization an important factor in botulinum toxin duration of action?

    Movement Disorders

    Volume 19, Issue S8, March 2004, Pages: S23–S34, Ester Fernández-Salas, Helen Ho, Patton Garay, Lance E. Steward and K. Roger Aoki

    Article first published online : 9 MAR 2004, DOI: 10.1002/mds.20006

  3. Molecular targets of botulinum toxin at the mammalian neuromuscular junction

    Movement Disorders

    Volume 19, Issue S8, March 2004, Pages: S7–S16, Dorothy D. Whelchel, Tonia M. Brehmer, Paula M. Brooks, Neely Darragh and Julie A. Coffield

    Article first published online : 9 MAR 2004, DOI: 10.1002/mds.20004

  4. Botulinum toxin A versus B in sialorrhea: A prospective, randomized, double-blind, crossover pilot study in patients with amyotrophic lateral sclerosis or Parkinson's disease

    Movement Disorders

    Volume 26, Issue 2, 1 February 2011, Pages: 313–319, Arianna Guidubaldi, Alfonso Fasano, Tamara Ialongo, Carla Piano, Maurizio Pompili, Roberta Mascianà, Luisa Siciliani, Mario Sabatelli and Anna Rita Bentivoglio

    Article first published online : 21 JAN 2011, DOI: 10.1002/mds.23473

  5. Botulinum toxin type B vs. type A in toxin-naïve patients with cervical dystonia: Randomized, double-blind, noninferiority trial

    Movement Disorders

    Volume 23, Issue 4, 15 March 2008, Pages: 510–517, Eric J. Pappert and Terry Germanson

    Article first published online : 20 DEC 2007, DOI: 10.1002/mds.21724

  6. Deciphering antibody properties that lead to potent botulinum neurotoxin neutralization

    Movement Disorders

    Volume 19, Issue S8, March 2004, Pages: S101–S108, James D. Marks

    Article first published online : 9 MAR 2004, DOI: 10.1002/mds.20023

  7. Efficacy and safety of repeated doses of botulinum toxin type B in type A resistant and responsive cervical dystonia

    Movement Disorders

    Volume 20, Issue 9, September 2005, Pages: 1152–1160, Stewart A. Factor, Eric S. Molho, Sharon Evans and Paul J. Feustel

    Article first published online : 13 JUN 2005, DOI: 10.1002/mds.20531

  8. Structure and enzymatic activity of botulinum neurotoxins

    Movement Disorders

    Volume 19, Issue S8, March 2004, Pages: S17–S22, Subramanyam Swaminathan, Subramanian Eswaramoorthy and Desigan Kumaran

    Article first published online : 9 MAR 2004, DOI: 10.1002/mds.20005

  9. Different types of botulinum toxin in humans

    Movement Disorders

    Volume 19, Issue S8, March 2004, Pages: S53–S59, Roberto Eleopra, Valeria Tugnoli, Rocco Quatrale, Ornella Rossetto and Cesare Montecucco

    Article first published online : 9 MAR 2004, DOI: 10.1002/mds.20010

  10. Ninhydrin sweat test: A simple method for detecting antibodies neutralizing botulinum toxin type A

    Movement Disorders

    Volume 19, Issue 8, August 2004, Pages: 943–947, Bernhard Voller, Ekaterina Moraru, Eduard Auff, Michael Benesch, Werner Poewe, Jörg Wissel, Jörg Müller, Tanja Entner, Hans Bigalke and Peter Schnider

    Article first published online : 4 MAR 2004, DOI: 10.1002/mds.20073

  11. BotDB: A database resource for the clostridial neurotoxins

    Movement Disorders

    Volume 19, Issue S8, March 2004, Pages: S35–S41, Frank J. Lebeda

    Article first published online : 9 MAR 2004, DOI: 10.1002/mds.20007

  12. Sensory disinhibition on passive movement in cervical dystonia

    Movement Disorders

    Volume 25, Issue 15, 15 November 2010, Pages: 2627–2633, Mark Obermann, Clemens Vollrath, Armin de Greiff, Elke R. Gizewski, Hans-Christoph Diener, Mark Hallett and Matthias Maschke

    Article first published online : 19 AUG 2010, DOI: 10.1002/mds.23321

  13. Anterior and posterior sagittal shift in cervical dystonia: A clinical and electromyographic study, including a new EMG approach of the longus colli muscle

    Movement Disorders

    Volume 26, Issue 13, November 2011, Pages: 2409–2414, Joanna M. Flowers, Lucy A. Hicklin and Marie-Helene Marion

    Article first published online : 12 SEP 2011, DOI: 10.1002/mds.23905

  14. Botulinum toxin treatment of epilepsia partialis continua

    Movement Disorders

    Volume 24, Issue 1, 15 January 2009, Pages: 141–143, Jun-Suk Kang, Karsten Krakow, Julia Roggendorf, Helmuth Steinmetz and Ruediger Hilker

    Article first published online : 14 OCT 2008, DOI: 10.1002/mds.22185

  15. Glucose hypermetabolism in the thalamus of patients with hemifacial spasm

    Movement Disorders

    Volume 27, Issue 4, April 2012, Pages: 519–525, Megumi Shimizu, Yukihisa Suzuki, Motohiro Kiyosawa, Masato Wakakura, Kenji Ishii, Kiichi Ishiwata and Manabu Mochizuki

    Article first published online : 16 FEB 2012, DOI: 10.1002/mds.24925

  16. Retargeted clostridial endopeptidases: Inhibition of nociceptive neurotransmitter release in vitro, and antinociceptive activity in in vivo models of pain

    Movement Disorders

    Volume 19, Issue S8, March 2004, Pages: S42–S47, John A. Chaddock, John R. Purkiss, Frances C.G. Alexander, Sarah Doward, Sarah J. Fooks, Lorna M. Friis, Yper H.J. Hall, Elizabeth R. Kirby, Nicola Leeds, Hilary J. Moulsdale, Anthony Dickenson, G. Mark Green, Wahida Rahman, Rie Suzuki, Michael J. Duggan, Conrad P. Quinn, Clifford C. Shone and Keith A. Foster

    Article first published online : 9 MAR 2004, DOI: 10.1002/mds.20008

  17. History of chorea: Part 3 of the MDS-sponsored history of movement disorders exhibit, Barcelona, June 2000

    Movement Disorders

    Volume 16, Issue 2, March 2001, Pages: 331–338, Christopher G. Goetz, Teresa A. Chmura and Douglas J. Lanska

    Article first published online : 12 MAR 2001, DOI: 10.1002/mds.1066

  18. Botulinum neurotoxins for post-stroke spasticity in adults: A systematic review

    Movement Disorders

    Volume 24, Issue 6, 30 April 2009, Pages: 801–812, Antonio Emanuele Elia, Graziella Filippini, Daniela Calandrella and Alberto Albanese

    Article first published online : 17 FEB 2009, DOI: 10.1002/mds.22452

  19. Botulinum neurotoxin type A injections reduce spasticity in mild to moderate hereditary spastic paraplegia— Report of 19 cases

    Movement Disorders

    Volume 23, Issue 2, 30 January 2008, Pages: 228–233, Martin J. Hecht, Henning Stolze, Matthias Auf Dem Brinke, Ralf Giess, Thoams Treig, Martin Winterholler, Jörg Wissel and German Spasticity Education Group

    Article first published online : 12 NOV 2007, DOI: 10.1002/mds.21809

  20. Safety and efficacy of botulinum toxin type B for treatment of sialorrhea in Parkinson's disease: A prospective double-blind trial

    Movement Disorders

    Volume 27, Issue 2, February 2012, Pages: 219–226, Robert Chinnapongse, Kristen Gullo, Paul Nemeth, Yuxin Zhang and Lynn Griggs

    Article first published online : 1 SEP 2011, DOI: 10.1002/mds.23929